Citi's recent 13F filing has unveiled a range of significant investments, showcasing the bank's strategic positioning in the financial sector. The filing, submitted on November 4, 2026, reveals that Citi holds substantial stakes in various companies, indicating a robust investment strategy aimed at diversifying its portfolio.

As one of the leading players in the National Commercial Banks sector, Citi continues to adapt and evolve its investment strategies to remain competitive. The latest filing reflects the bank's ongoing commitment to identifying promising investment opportunities across different industries.

Background

Citi, officially known as Citigroup Inc, operates under the Standard Industrial Classification (SIC) code 6021, which designates it as a National Commercial Bank. The company is listed on the New York Stock Exchange under the ticker symbols C, C-PN, and C-PR. With a long history in the banking sector, Citi has established itself as a significant player in the financial services industry.

What the Filing Says

The 13F filing, which covers the period ending September 30, 2026, indicates that Citi's total reported holdings amount to approximately $308.3 billion. The filing includes a detailed breakdown of investments, with notable stakes in companies such as WhiteHawk Therapeutics Inc and AAON Inc. The document highlights a total of 12,011 entries, showcasing the breadth of Citi's investment strategy.

Impact

This filing may affect various stakeholders, including investors, analysts, and competitors within the National Commercial Banks sector. By revealing its investment choices, Citi provides insights into its strategic direction, which could influence market perceptions and investment decisions among peers and investors alike.

What's Next

The filing does not specify what actions Citi plans to take next regarding these investments. However, the ongoing monitoring of these holdings and potential adjustments in response to market conditions will likely be a focus for Citi's management team.

Source: SEC Accession Number 0000831001-26-000052